Analysis of the information provided indicate that the cause for the discordant elevated tpsa result is unknown.No samples have been provided to siemens for investigation.Siemens headquarters support center has evaluated the information provided.The data is discordant high relative to the siemens alternate methodology, advia centaur.The instructions for use(ifu) for the dimension® tpsa flex® reagent cartridge contains the following information: "warning: the concentration of tpsa in a given specimen determined with assays from different manufacturers can vary due to differences in assay methods and reagent specificity.The results reported by the laboratory to the physician must include the identity of the psa assay used.Values obtained with different assay methods cannot be used interchangeably.If, in the course of monitoring a patient, the assay method used for determining psa levels serially is changed, additional sequential testing should be carried out.Prior to changing assays, the laboratory must confirm baseline values for patients being serially monitored." in the limitations of procedure section of the ifu it is also stated: "patient samples may contain heterophilic antibodies that could react in immunoassays to give falsely elevated or depressed results.This assay has been designed to minimize interference from heterophilic antibodies.Nevertheless, complete elimination of this interference from all patient specimens cannot be guaranteed.A test result that is inconsistent with the clinical picture and patient history should be interpreted with caution.".
|